Literature DB >> 9668262

Thymus, thymoma, and specific T cells in myasthenia gravis.

D Beeson1, A P Bond, L Corlett, S J Curnow, M E Hill, L W Jacobson, C MacLennan, A Meager, A M Moody, P Moss, N Nagvekar, J Newsom-Davis, N Pantic, I Roxanis, E G Spack, A Vincent, N Willcox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668262     DOI： 10.1111/j.1749-6632.1998.tb10950.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08.

Authors:  Peter K Gregersen; Roman Kosoy; Annette T Lee; Janine Lamb; Jon Sussman; David McKee; Kim R Simpfendorfer; Ritva Pirskanen-Matell; Frederik Piehl; Qiang Pan-Hammarstrom; Jan J G M Verschuuren; Maarten J Titulaer; Erik H Niks; Alexander Marx; Philipp Ströbel; Björn Tackenberg; Michael Pütz; Angelina Maniaol; Ahmed Elsais; Chantal Tallaksen; Hanne F Harbo; Benedicte A Lie; Soumya Raychaudhuri; Paul I W de Bakker; Arthur Melms; Henri-Jean Garchon; Nicholas Willcox; Lennart Hammarstrom; Michael F Seldin
Journal:  Ann Neurol       Date:  2012-10-10       Impact factor: 10.422

2.  LncRNA and mRNA expression associated with myasthenia gravis in patients with thymoma.

Authors:  Ji Ke; Xin Du; Jian Cui; Lei Yu; Hui Li
Journal:  Thorac Cancer       Date:  2021-11-12       Impact factor: 3.500
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.